scispace - formally typeset
W

Wenyi Wang

Researcher at University of Texas MD Anderson Cancer Center

Publications -  123
Citations -  22012

Wenyi Wang is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Biology. The author has an hindex of 28, co-authored 92 publications receiving 16322 citations. Previous affiliations of Wenyi Wang include Johns Hopkins University & University of Texas Health Science Center at Houston.

Papers
More filters
Journal ArticleDOI

MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data

TL;DR: The accuracy of MuSE is demonstrated in calling subclonal mutations in the context of large-scale tumor sequencing projects using whole exome and whole genome sequencing.
Journal ArticleDOI

PancPRO: Risk Assessment for Individuals With a Family History of Pancreatic Cancer

TL;DR: PancPRO is the first risk prediction model for pancreatic cancer risk prediction in individuals with familial Pancreas Tumor Registry and demonstrates that accurate genetic risk assessment is possible even when the causative genes are not known.
Journal ArticleDOI

Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes

Stefan C. Dentro, +87 more
- 15 Apr 2021 - 
TL;DR: In this article, the authors extensively characterize intra-tumor heterogeneity (ITH) across whole-genome sequences of 2,658 cancer samples spanning 38 cancer types and identify cancer type-specific subclonal patterns of driver gene mutations, fusions, structural variants, and copy number alterations.
Posted ContentDOI

Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes

TL;DR: The results underline the importance of ITH and its drivers in tumor evolution, and provide an unprecedented pan-cancer resource of comprehensively annotated subclonal events from whole-genome sequencing data.
Journal ArticleDOI

Proteogenomic characterization of pancreatic ductal adenocarcinoma

Liwei Cao, +139 more
- 16 Sep 2021 - 
TL;DR: In this article, a comprehensive proteogenomic analysis of 140 pancreatic cancers, 67 normal adjacent tissues, and 9 normal pancreatic ductal tissues was conducted to understand the underlying molecular alterations that drive PDAC oncogenesis.